FDA Clears Blood Test to Detect Alzheimer's in Primary and Specialty Care

(MedPage Today) -- The FDA cleared the Elecsys pTau217 blood test to identify amyloid-beta pathology associated with Alzheimer's disease in people ages 55 and older with symptoms of cognitive decline, Roche announced Monday. The test, developed...